Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies

被引：162

作者：

Wolf, Denise M. ^{[1
]}

Yau, Christina ^{[2
]}

Wulfkuhle, Julia ^{[3
]}

Brown-Swigart, Lamorna ^{[1
]}

Gallagher, Rosa, I ^{[3
]}

Lee, Pei Rong Evelyn ^{[1
]}

Zhu, Zelos ^{[2
]}

Magbanua, Mark J. ^{[1
]}

Sayaman, Rosalyn ^{[1
]}

O'Grady, Nicholas ^{[2
]}

Basu, Amrita ^{[2
]}

Delson, Amy ^{[4
]}

Coppe, Jean Philippe ^{[1
]}

Lu, Ruixiao ^{[5
]}

Braun, Jerome ^{[5
]}

Asare, Smita M. ^{[5
]}

Sit, Laura ^{[2
]}

Matthews, Jeffrey B. ^{[2
]}

Perlmutter, Jane ^{[6
]}

Hylton, Nola ^{[7
]}

Liu, Minetta C. ^{[8
]}

Pohlmann, Paula ^{[9
]}

Symmans, W. Fraser ^{[10
]}

Rugo, Hope S. ^{[11
]}

Isaacs, Claudine ^{[12
]}

DeMichele, Angela M. ^{[13
]}

Yee, Douglas ^{[14
]}

Berry, Donald A. ^{[15
]}

Pusztai, Lajos ^{[16
]}

Petricoin, Emanuel F. ^{[3
]}

Hirst, Gillian L. ^{[2
]}

Esserman, Laura J. ^{[2
]}

Veer, Laura J. van 't ^{[1
]}

机构：

[1] Univ Calif San Francisco, Dept Lab Med, 2340 Sutter St, San Francisco, CA 94143 USA

[2] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA

[3] George Mason Univ, Ctr Appl Prote & Mol Med, Manassas, VA USA

[4] Univ Calif San Francisco, Breast Sci Advocacy Core, San Francisco, CA 94143 USA

[5] Quantum Leap Healthcare Collaborat, San Francisco, CA 94118 USA

[6] Gemini Grp, Ann Arbor, MI 48107 USA

[7] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA

[8] Mayo Clin, Dept Surg, Rochester, MN 55905 USA

[9] Georgetown Univ, MedStar Georgetown Univ Hosp, Washington, DC 20057 USA

[10] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA

[11] Univ Calif San Francisco, Div Hematol Oncol, San Francisco, CA 94158 USA

[12] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA

[13] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA

[14] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA

[15] Berry Consultants LLC, Austin, TX 78746 USA

[16] Yale Univ, Yale Sch Med, New Haven, CT 06510 USA

来源：

CANCER CELL | 2022年 / 40卷 / 06期

关键词：

STANDARD NEOADJUVANT CHEMOTHERAPY; ADAPTIVE RANDOMIZATION; TREATMENT DECISIONS; 70-GENE SIGNATURE; CARBOPLATIN; TRIAL; AID;

D O I：

10.1016/j.ccell.2022.05.005

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Using pre-treatment gene expression, protein/phosphoprotein, and clinical data from the I-SPY2 neoadjuvant platform trial (NCT01042379), we create alternative breast cancer subtypes incorporating tumor biology beyond clinical hormone receptor (HR) and human epidermal growth factor receptor-2 (HER2) status to better predict drug responses. We assess the predictive performance of mechanism-of-action biomarkers from similar to 990 patients treated with 10 regimens targeting diverse biology. We explore >11 subtyping schemas and identify treatment-subtype pairs maximizing the pathologic complete response (pCR) rate over the population. The best performing schemas incorporate Immune, DNA repair, and HER2/Luminal phenotypes. Subsequent treatment allocation increases the overall pCR rate to 63% from 51% using HR/HER2-based treatment selection. pCR gains from reclassification and improved patient selection are highest in HR+ subsets (>15%). As new treatments are introduced, the subtyping schema determines the minimum response needed to show efficacy. This data platform provides an unprecedented resource and supports the usage of response-based subtypes to guide future treatment prioritization.

引用

页码：609 / +

页数：22

共 52 条

[51] Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial
Yee, Douglas
DeMichele, Angela M.
Yau, Christina
Isaacs, Claudine
Symmans, W. Fraser
Albain, Kathy S.
Chen, Yunn-Yi
Krings, Gregor
Wei, Shi
Harada, Shuko
Datnow, Brian
Fadare, Oluwole
Klein, Molly
Pambuccian, Stefan
Chen, Beiyun
Adamson, Kathi
Sams, Sharon
Mhawech-Fauceglia, Paulette
Magliocco, Anthony
Feldman, Mike
Rendi, Mara
Sattar, Husain
Zeck, Jay
Ocal, Idris T.
Tawfik, Ossama
LeBeau, Lauren Grasso
Sahoo, Sunati
Vinh, Tuyethoa
Chien, A. Jo
Forero-Torres, Andres
Stringer-Reasor, Erica
Wallace, Anne M.
Pusztai, Lajos
Boughey, Judy C.
Ellis, Erin D.
Elias, Anthony D.
Lu, Janice
Lang, Julie E.
Han, Hyo S.
Clark, Amy S.
Nanda, Rita
Northfelt, Donald W.
Khan, Qamar J.
Viscusi, Rebecca K.
Euhus, David M.
Edmiston, Kirsten K.
Chui, Stephen Y.
Kemmer, Kathleen
Park, John W.
Liu, Minetta C.
[J]. JAMA ONCOLOGY, 2020, 6 (09) : 1355 - 1362
[52] Zeileis A., 2002, R NEWS, V2, P7

← 1 2 3 4 5 6 →